Selection from: Hypogonadism and Type 2 Diabetes: Relationships and Clinical Perspectives
Hypogonadism and Type 2 Diabetes: Relationships and Clinical Perspectives CME
Andre T. Guay, MD, FACP, FACE Kenneth J. Snow, MD Disclosures
Pre-Assessment: Measuring Educational Impact
To help us assess the effectiveness of our medical education programs, please take a few moments to read the following cases and complete the questions that follow before participating in the CME activity.
1. In your experience, which of the following is the most important barrier to the optimal management of male patients with low testosterone level? Not including hypogonadism in the differential diagnosis list in at-risk men Lack of consensus in testosterone level below which therapy is indicated in patients with signs and symptoms of hypogonadism Fear of increased rate of prostate cancer as a result of testosterone therapy Normal testosterone level in otherwise healthy patients with signs and symptoms of hypogonadism
2. How confident are you that you are up-to-date in the diagnosis and management of male patients with low testosterone level? Not at all confident Somewhat confident Confident Very confident Copyright © 2007 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written consent of Joslin Diabetes Center is prohibited.
This is a part of article Hypogonadism and Type 2 Diabetes: Relationships and Clinical Perspectives Taken from "Viagra Levitra" Information Blog
No comments:
Post a Comment